L. Brannon-Peppas
Advanced Drug Delivery Reviews · 2004–2008
A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 7 researchers here, as inferred from the citation graph.
Who trusts L. Brannon-Peppas overall
Papers from L. Brannon-Peppas's perspective
Ordered by how strongly the researchers L. Brannon-Peppas trusts endorse each paper. Same corpus, a different order for every researcher.
- Paclitaxel and its formulations. (International journal of pharmaceutics)
- Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. (Journal of Controlled Release)
- Nanoparticles in cancer therapy and diagnosis. (Advanced Drug Delivery Reviews)
- A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. (Journal of Controlled Release)
- Chitosan as a novel nasal delivery system for vaccines. (Advanced Drug Delivery Reviews)
- Chitosan: some pharmaceutical and biological aspects ‐ an update (The Journal of pharmacy and pharmacology)
- Function and interactions of integrins (Cell and Tissue Research)
- Role of target geometry in phagocytosis. (Proceedings of the National Academy of Sciences of the United States of America)
- Recent advances with liposomes as pharmaceutical carriers (Nature reviews. Drug discovery)
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Active targeting schemes for nanoparticle systems in cancer therapeutics. (2008) — 1,645 citations
- Nanoparticle and targeted systems for cancer therapy. (2004) — 2,492 citations